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Research
Substantial epidemiologic evidence links par-
ticulate air pollution to adverse acute cardio-
vascular health effects. Associations are
generally consistent across studies and robust
to adjustment by smoking, weather, and sea-
sonality (Brook et al. 2004). Although the
biologic mechanisms behind these associa-
tions remain uncertain, several investigators
have hypothesized that oxidative stress in the
lungs from inhaled particulate matter (PM)
leads to a systemic inﬂammatory cascade that
can increase cardiovascular risk among sus-
ceptible individuals. This elevated risk can
occur via increased coagulability of the blood
(Seaton et al. 1995) or development and
destabilization of atherosclerotic plaques
(Donaldson et al. 2001).
The hypothesized role of inﬂammation in
PM-mediated toxicity is well supported by past
ﬁndings. Researchers have associated PM with
influxes of inflammatory cells into the lungs
(Ghio et al. 2000), enhanced production of
proinflammatory cytokines by alveolar
macrophages (van Eeden et al. 2001), elevated
systemic blood viscosity (Pekkanen et al. 2000;
Peters et al. 1997), and increased production
of inflammatory cells by bone marrow (Tan
et al. 2000). Acute peripheral artery narrowing
(Brook et al. 2002), arterial reactivity (O’Neill
et al. 2005), extent of atherosclerotic lesions
(Kunzli et al. 2005; Suwa et al. 2002), and ele-
vated risk of myocardial infarctions (Peters
et al. 2001a; Zanobetti and Schwartz 2005)
also have been associated with PM. In addi-
tion, relationships have been found between
PM and C-reactive protein (CRP) (Peters et al.
2001b; Pope et al. 2004; Riediker et al. 2004;
Seaton et al. 1999), an inﬂammatory marker
that has been shown to be predictive of cardio-
vascular disease (Danesh et al. 2004; Ridker
et al. 2000).
Past investigations also have demonstrated
that the cardiovascular impacts of air pollution
are not the same for all individuals. Enhanced
susceptibility for air pollution–related cardio-
vascular events has been shown for older indi-
viduals and persons with conditions associated
with chronic inflammation such as diabetes,
coronary artery disease, and past myocardial
infarctions (Bateson and Schwartz 2004;
Goldberg et al. 2001; Zanobetti and Schwartz
2002). Based on these ﬁndings, it is conceiv-
able that the short-term effects of PM on
inflammation also may be enhanced among
individuals with existing inﬂammation. Little
has been published to answer this question,
however. Therefore, the goals of this analysis
were to evaluate short-term associations
between ambient PM and markers of systemic
inflammation in older adults and to explore
susceptibility by conditions linked to chronic
inflammation such as diabetes, obesity, and
hypertension (Libby 2002).
Materials and Methods
Study population. Data were collected from
44 nonsmoking seniors (≥ 60 years of age)
between March and June of 2002 under the
supervision of the Harvard School of Public
Health Human Subjects Committee. All par-
ticipants were independently mobile and lived
in one of four independent senior residences
in suburban St. Louis, Missouri. Individuals
with atrial ﬂutter, atrial ﬁbrillation, and/or a
paced rhythm were excluded from participa-
tion because heart rate variability also was
assessed during this investigation. Similarly,
participants with left bundle branch blocks
were selected only if their heart rate variability
could be ascertained. Individuals with unsta-
ble angina and persons who were unable to
provide informed written consent also were
excluded from participation.
Study design. Data for this analysis were
collected as part of a more comprehensive
investigation designed to examine the cardio-
vascular health effects of trafﬁc-related pollu-
tion. The main goal of this investigation,
which included continuous electrocardiogram
measurements, was to evaluate if cumulative
exposures to fresh trafﬁc-related pollution or
even moment-to-moment changes in traffic
pollution would influence autonomic func-
tion in the elderly. To meet this objective,
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Airborne particulate matter (PM) may lead to increased cardiac risk through an inflammatory
pathway. Therefore, we investigated associations between ambient PM and markers of systemic
inﬂammation among repeated measures from 44 senior citizens (≥ 60 years of age) and examined
susceptibility by conditions linked to chronic inﬂammation. Mixed models were used to identify
associations between concentrations of ﬁne PM [aerodynamic diameter ≤ 2.5 µm (PM2.5)] aver-
aged over 1–7 days and measures of C-reactive protein (CRP), interleukin-6 (IL-6), and white
blood cells (WBCs). Effect modiﬁcation was investigated for diabetes, obesity, hypertension, and
elevated mean inflammatory markers. We found positive associations between longer moving
averages of PM2.5 and WBCs across all participants, with a 5.5% [95% conﬁdence interval (CI),
0.10 to 11%] increase per interquartile increase (5.4 µg/m3) of PM2.5 averaged over the previous
week. PM2.5 and CRP also exhibited positive associations among all individuals for averages
longer than 1 day, with the largest associations for persons with diabetes, obesity, and hyperten-
sion. For example, an interquartile increase in the 5-day mean PM2.5 (6.1 µg/m3) was associated
with a 14% increase in CRP (95% CI, –5.4 to 37%) for all individuals and an 81% (95% CI, 21
to 172%) increase for persons with diabetes, obesity, and hypertension. Persons with diabetes,
obesity, and hypertension also exhibited positive associations between PM2.5 and IL-6. Individuals
with elevated mean inﬂammatory markers exhibited enhanced associations with CRP, IL-6, and
WBCs. We found modest positive associations betweenPM2.5 and indicators of systemic inﬂam-
mation, with larger associations suggested for individuals with diabetes, obesity, hypertension, and
elevated mean inﬂammatory markers. Key words: air pollution, C-reactive protein, inﬂammation,
metabolic syndrome, particulate matter, susceptibility. Environ Health Perspect 114:992–998
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pate in a series of four group trips into St.
Louis for a brief activity and lunch. All trips
ranged from approximately 0945 hr to
1430 hr and included two 1-hr rides aboard a
diesel-powered shuttle bus. Subjects partici-
pated approximately once per month along
with two to seven other individuals from
their residence facility, resulting in a total of
25 trips.
A second aim of this study was to examine
associations between fresh trafﬁc-related pollu-
tion and ambient pollution on markers of
inﬂammation. As part of this exploratory inves-
tigation, we collected venous blood samples at
approximately 0900 hr on the morning after
each trip. Questionnaires regarding medication
and vitamin use, food consumption, and
health status were also administered at that
time. Blood pressure, height, and weight data
were collected before participation in any trips.
Blood analyses. Venous blood was collected
per participant per trip. Each sample was ana-
lyzed promptly for white blood cells (WBCs)
at the Barnes Jewish Hospital using a Coulter
Ge-S system (Beckman Coulter Inc., Fullerton,
CA). The remaining plasma was extracted by
the Washington University Core Laboratory
for Clinical Studies (St. Louis, MO), preserved
at –80°C, and shipped to the Clinical and
Epidemiologic Research Laboratory at Boston
Children’s Hospital. Samples stored with
sodium citrate were analyzed for CRP using
immunoturbidimetric assays on the Hitachi
917 Chemistry Analyzer (Roche Diagnostics,
Indianapolis, IN) with reagents and calibra-
tions from Denka Seiken (Niigata, Japan).
Interleukin-6 (IL-6) was analyzed using
enzyme-linked immunosorbent assays from
R&D Systems (Minneapolis, MN). Only sam-
ples with sufficient blood for all three assays
were included in our analysis.
Exposure measurements. Ambient PM data
were obtained from the U.S. Environmental
Protection Agency (EPA)–funded Supersite in
East St. Louis, Illinois. Concentrations of PM
with aerodynamic diameter ≤ 2.5 µm (PM2.5)
were recorded using a continuous ambient
mass monitor (Andersen Instruments; Smyrna,
GA) with a Nafion diffusion dryer (Perma
Pure, Toms River, NJ). Ambient black carbon
(BC) was reported using a aethalometer
(McGee Scientiﬁc, Berkeley, CA).
Additional measurements of group-level
PM2.5 were collected during the 48 hr preced-
ing each blood draw in order to better capture
participants’ true exposures. These samples
were collected continuously from participants’
microenvironments using a portable cart that
followed subjects from a centrally located area
in their living facility, onto the bus, to the
activity and lunch, and finally back to their
housing facility again. Installed on these carts
were a DustTrak 8520 aerosol monitor (TSI
Inc., Shoreview, MN) and Nafion diffusion
drier. A Harvard Impactor (Air Diagnostics
Environmental Inc., Harrison, ME) also was
positioned on the carts as a means to calibrate
the DustTrak samples because the DustTrak
has been shown to overestimate concentrations
despite being well correlated with several refer-
ence methods (Chang et al. 2001).
Gaseous criteria pollutant data were
obtained from the Missouri Department of
Natural Resources and the Illinois Environ-
mental Protection Agency monitoring station,
located immediately adjacent to the Supersite.
These ambient measurements were collected
using a TEI 48 analyzer (Thermo Environ-
mental Instruments, Franklin, MA) for carbon
monoxide, an API 200A analyzer (Teledyne,
San Diego, CA) for nitrogen dioxide, a Dasibi
4108 analyzer (Dasibi, Glendale, CA) for sul-
fur dioxide, and a Dasibi 1008RS analyzer for
ozone. Meteorologic parameters also were
obtained from the Missouri Department of
Natural Resources station and used to calcu-
late ambient apparent temperature, a biologic
weather stress index (O’Neill et al. 2003).
Indoor apparent temperature was calculated
using data from a HOBO data logger (Onset
Computer, Bourne, MA) in the participants’
microenvironments. Daily mold and pollen
data were obtained from the county health
department and examined as total counts.
Statistical analysis. We used linear mixed
models (SAS, version 8.02; SAS Institute Inc.,
Cary, NC) to evaluate relationships between
air pollution and markers of inﬂammation. To
account for correlation among the multiple
measurements collected per person, our models
included random intercepts for each subject.
Although autoregressive terms were evaluated,
they were ultimately not used because likeli-
hood ratio tests indicated that they were
unnecessary. Random slopes were not consid-
ered because a maximum of four samples was
collected from any one individual.
Exposures were evaluated in our statistical
models using ambient pollutant concentrations
averaged over the 1–7 days preceding each
blood draw. These averaging times were calcu-
lated using hourly pollution data measured at
the St. Louis Supersite and were selected based
on the findings of past investigations, which
found associations with indicators of inﬂam-
mation on the order of days to 1 week (Peters
et al. 2001b; Seaton et al. 1999). Although our
main analysis focused on moving averages, we
also assessed the impact of lagged ambient
concentrations ranging from 1 to 7 days to
confirm our findings. In addition, models
were run using microenvironmental PM2.5
measurements averaged over the 1 and 2 days
before the health measurements to examine
the effects of measurement error on resulting
effect estimates. (Longer averaging times for
microenvironmental exposures could not be
examined because they were measured only
during the 2 days before the blood draws.)
Before statistical modeling, all outcome
variables were transformed logarithmically
because each was highly skewed. Univariate
models were then run to examine the impact
of various individual characteristics on the
outcomes. Next, single-pollutant models for
each moving average were used to evaluate
ambient PM2.5 as a potential predictor of
each inﬂammatory marker. Additional models
containing a moving average of ambient BC,
NO2, SO2, O3, or microenvironmental
PM2.5 were run to confirm our ambient
PM2.5 results. Due to limited samples and our
interest in effect modiﬁcation, multipollutant
models were generally not employed because
of power constraints. Effect estimates from
our models and their 95% confidence inter-
vals (CIs) were transformed into percent
changes and reported per interquartile range
(IQR) of a pollutant.
All models were controlled for sex, obesity,
diabetes, and smoking history (ever/never).
Time-varying parameters considered as poten-
tial confounders included apparent tempera-
ture, hour, day, trip (a proxy of activity and
season), residence, mold, pollen, illness, and
juice intake. Medication and vitamin con-
sumption on the day of the blood draw was
also examined, with speciﬁc focus on medica-
tions that might influence inflammation or
oxidative stress (i.e., statins, inhaled steroids,
aspirin, ibuprofen, and vitamins). Respiratory
medications other than inhaled steroids were
not examined because of insufficient daily
variation. Of all the potential confounders
evaluated, we selected ambient and micro-
environmental apparent temperature, mold,
pollen, vitamins, trip, and hour for our mod-
els based on a significant relationship with
one of the outcomes at the 0.2 level among
the unexposed (lower 50th percentile by
exposure) (Mickey and Greenland 1989).
Trip, hour, and vitamins were included in our
models as categorical terms. All other vari-
ables were modeled as linear except for mold,
which was treated as a linear spline with one
knot for WBCs. These parameterizations
were selected using loess smoothing in S-Plus
2000 (MathSoft, Cambridge, MA) as well as
likelihood ratio tests and Akaike information
criterion comparisons in SAS. Residual checks
conﬁrmed the parameterization of our mod-
els, and sensitivity analyses indicated that our
findings were qualitatively robust to con-
founder selection.
Effect modification by conditions linked
to chronic inflammation was investigated
using interaction terms for diabetes, obesity,
and hypertension. An indicator for concur-
rent diabetes, obesity, and hypertension was
also created. For this analysis, we deﬁned obe-
sity by a body mass index ≥ 30 kg/m2 and
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of diabetes medications. Hypertension was
deﬁned as a systolic blood pressure ≥ 140 mm
Hg, diastolic blood pressure ≥ 90 mm Hg,
and/or taking hypertensive medications.
A confirmatory analysis also was con-
ducted to compare individuals with elevated
mean inflammatory markers throughout the
study to the rest of the population. Because
baseline measurements were unavailable, indi-
viduals were classiﬁed in the elevated marker
group if their mean CRP, IL-6, or WBC levels
across all samples were within the top 25th
percentile of the study population. In absolute
terms, these categories were deﬁned as having
a mean CRP concentration > 5.7 mg/L, a
mean IL-6 concentration > 4.6 pg/mL, or a
mean WBC concentration > 7.7 × 109/L.
Indicators were created for each inﬂammatory
outcome individually. Effect modiﬁcation by
statin therapy also was examined.
Results
Inﬂammatory markers. In total, 25 group trips
were conducted over the duration of the study,
with most (35 of 44) subjects participating in
each of their four trips. Of the 158 completed
person-trips, we obtained 133 samples with
sufficient volume for complete laboratory
analysis. Samples were predominantly missing
because of the lack of a phlebotomist or insufﬁ-
cient blood volume collected.
Overall summary statistics for the CRP,
IL-6, and WBC levels of our samples are pre-
sented by subject characteristics in Table 1.
Our 44 participants were predominantly
white females with a median age of 80 years.
In general, higher median levels of inﬂamma-
tion across our repeated samples were
observed among individuals with diabetes,
obesity, and/or hypertension than those with-
out these conditions, although few of these
differences were signiﬁcant at the 95% conﬁ-
dence level. Similarly, median levels of
inflammatory markers were slightly lower
among those on statin therapy but not statis-
tically different than those who were not.
Exposure parameters. Table 2 summarizes
the mean air pollution, pollen, mold, and
apparent temperature levels for the day pre-
ceding each blood draw. Longer moving aver-
ages exhibited similar means but smaller
ranges and standard deviations. Mean micro-
environmental concentrations of PM2.5 were
generally lower than ambient levels, although
the range of values was somewhat compara-
ble. Microenvironmental apparent tempera-
ture was more moderate and less variable than
the apparent temperature outdoors. All pollu-
tants were measured at levels well below cur-
rent U.S. National Ambient Air Quality
Standards (U.S. EPA 2006). 
Daily concentrations of ambient PM2.5
and BC were positively correlated in both
spring (r = 0.6) and summer (r = 0.7),
whereas microenvironmental PM2.5 was only
positively correlated with daily ambient
PM2.5 and BC during the summer (r = 0.73
and r = 0.30, respectively). Higher summer-
time correlations between the ambient and
microenvironmental measurements corre-
sponded to an increased frequency of open
windows during the summer. Seasonal varia-
tion also was observed for O3, a marker for
regional pollution, which exhibited positive
correlations with daily ambient PM2.5 during
the summer (r = 0.2) but inverse correlations
during the spring (r = –0.7).
Ambient PM2.5 and inﬂammation. WBC
counts were positively associated with ambi-
ent PM2.5 across the whole population. These
associations increased with longer moving
averages and reached statistical significance
with the 7-day mean (Figure 1), where an
IQR increase in PM2.5 of 5.4 µg/m3 was asso-
ciated with a 5.5% increase in WBC counts
(95% CI, 0.10–11). Associations with WBC
counts remained significantly elevated
through the 14-day mean (data not shown)
but declined with longer moving averages.
Ambient PM2.5 also was associated with CRP
across the entire population with positive but
Dubowsky et al.
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Table 1. Levels of inﬂammatory markers by participant characteristics.
Median (range)
Subjects [n(%)] Samples (n) CRP (mg/L) IL-6 (pg/mL) WBCs (× 109/L)
All participants 44 (100) 133 2.2 (0.25–41) 2.9 (0.98–18) 6.4 (3.4–11)
Sex
Female 36 (82) 107 2.8 (0.25–41) 2.9 (0.98–18) 6.7 (3.4–11)
Male 8 (18) 26 1.1 (0.27–15) 3.0 (1.0–14) 5.6 (3.9–8.4)
Race
White  41 (93) 125 2.5 (0.25–38) 2.9 (1.0–18) 6.4 (3.4–11)
African American 3 (7) 8 1.2 (0.69–41) 2.7 (0.98–5.1) 4.8 (4.3–6.8)
Age (years)
60–79 19 (43) 56 3.0 (0.26–41) 2.8 (0.98–18) 6.4 (4.5–9.0)
80–95 25 (57) 77 1.7 (0.25–38) 2.9 (1.0–14) 6.3 (3.4–11)
Cigarette smoking
Former 21 (48) 63 2.7 (0.25–41) 3.4 (0.98–18)* 6.7 (3.9–10)
Never 23 (52) 70 2.2 (0.26–19) 2.7 (1.0–14)* 6.1 (3.4–11)
Diabetes
Yes 8 (18) 26 3.3 (0.27–19) 2.7 (1.0–7.2) 7.2 (4.3–11)
No 36 (82) 107 2.1 (0.25–41) 2.9 (0.98–18) 6.3 (3.4–11)
Obesity
Yes 14 (32) 41 4.8 (0.66–41) 3.0 (0.98–7.2) 7.2 (4.6–11)*
No 30 (68) 92 1.7 (0.25–38) 2.7 (1.0–18) 6.0 (3.4–9.4)*
Hypertension
Yes 36 (82) 108 2.6 (0.25–41) 3.0 (0.98–18) 6.6 (3.9–11)*
No 8 (18) 25 1.8 (0.26–6.8) 1.9 (1.1–6.1) 5.4 (3.4–8.1)*
Diabetes with obesity
and hypertension
Yes 4 (9) 14 5.4 (0.66–19) 3.8 (2.1–7.2) 8.2 (4.6–11)
No 40 (91) 119 1.9 (0.25–41) 2.7 (0.98–18) 6.3 (3.4–11)
Statin therapy
Yes 10 (23) 33 2.2 (0.025–6.8) 2.7 (1.2–14) 6.3 (4.7–8.5)
No 34 (77) 100 2.4 (0.026–41) 2.9 (0.98–18) 6.5 (3.4–11)
*Groups were signiﬁcantly different at the 0.05 level in a univariate model with random subject effects.
Table 2. Descriptive statistics for pollution, biologic, and meteorologic variables (1-day averages).
No. Quartile
samples Mean ± SD 0th 25th 75th 100th
Ambient
PM2.5 (µg/m3) 24 16 ± 6.0 6.5 12 22 28
BC (ng/m3) 24 900 ± 280 290 730 1,100 1,400
CO (ppm) 22 0.43 ± 0.13 0.096 0.38 0.49 0.66
NO2 (ppb) 21 17 ± 3.3 11 15 19 22
SO2 (ppb) 23 6.7 ± 8.2 1.2 2.1 7.4 27
O3 (ppb) 22 24 ± 9.4 1.2 17 29 44
Mold counts (pt/m3) 24 18,000 ± 20,000 1,000 3,500 27,000 68,000
Pollen counts (pt/m3) 24 480 ± 1,000 6.00 44 390 4,600
Apparent temperature (°C)a 24 17 ± 9.7 –2.5 9.2 24 31
Microenvironmental
PM2.5 (µg/m3) 23 9.8 ± 4.5 3.5 7.1 11 22
Apparent temperature (°C)a 24 23 ± 2.1 19 21 23 27
A maximum of 24 trips was included in this analysis because data from one trip was lost due to last-minute cancellation
by our phlebotomist.
aApparent temperature was calculated by –2.653 + (0.994 × temperature in °C) + [0.0153 × (dew point temperature in °C)2]
(O’Neill et al. 2003).nonsignificant relationships. These relation-
ships were observed for all moving averages
longer than 1 day and peaked with the 5-day
mean. For IL-6, nonsigniﬁcant negative asso-
ciations with ambient PM2.5 were observed
among the population as a whole. Analyses of
pollution lagged by 1–7 days were consistent
with these findings. Similarly, associations
with microenvironmental PM2.5 averaged
over the previous 1 and 2 days demonstrated
similar, although often larger, associations
with each of the outcomes. (Longer averaging
times for microenvironmental concentrations
could not be examined, given that they were
only measured during the 2 days before the
blood draws.)
Effect modification by conditions linked
to inﬂammation. Evidence of effect modiﬁca-
tion was most frequently observed with CRP.
Associations between PM2.5 and CRP were
consistently, and often signiﬁcantly, elevated
among the 8 individuals with diabetes (26
repeated samples), 14 individuals with obesity
(41 repeated samples), and 4 individuals with
concurrent diabetes, obesity, and hyperten-
sion (14 repeated samples) (Figure 2). For
example, an IQR (6.1 µg/m3) increase in the
5-day mean PM2.5 was associated with a 48%
increase (95% CI, 5.3–109) in CRP for per-
sons with obesity, a 74% increase (95% CI,
18–158) for persons with diabetes, and an
81% increase (95% CI, 21–172) in CRP for
persons with diabetes, obesity, and hyperten-
sion compared with a 12% increase (95% CI,
–25 to 67) for individuals without any of
these conditions. Individuals with diabetes
and those with concurrent diabetes, obesity,
and hypertension also demonstrated larger
associations between PM2.5 and IL-6
(Figure 3). No evidence of effect modiﬁcation
was observed among the 36 individuals with
hypertension, nor did any of the conditions
evaluated significantly modify WBC counts
(data not shown). Individuals within the top
quartile of mean circulating inflammatory
markers also showed larger increases in
repeated measures of CRP, IL-6, and WBCs
with increases in ambient PM2.5 (Figure 4).
Identical results were produced if the median
inﬂammatory level was used to deﬁne individ-
uals with elevated inflammatory levels.
Conversely, the 10 individuals on anti-
inflammatory statin therapy demonstrated
nonsignificant reductions in the association
between ambient PM2.5 and CRP compared
with those not on statin therapy.
Other ambient pollution metrics and
inflammation. Individuals with concurrent
diabetes, obesity, and hypertension exhibited
large positive associations between ambient
BC, NO2, and O3 and CRP and IL-6, as
shown for the 5-day moving average concen-
trations in Table 3. These associations exhib-
ited similar patterns to those for ambient
PM2.5 at all moving averages. WBC counts
generally increased with IQR changes in
ambient BC, CO, and NO2, whereas inverse
associations were observed between WBC
counts and O3. Inconsistent findings were
observed with SO2.
Discussion
In this investigation, we found evidence of
positive associations between air pollution
and indicators of systemic inﬂammation (e.g.,
WBCs, CRP, and IL-6) in older adults. These
ﬁndings support the hypothesis that systemic
inﬂammation is a pathway through which air-
borne PM leads to short-term increases in car-
diac risk. We also found that the associations
with CRP and IL-6 were strongest and most
consistent for the 8 individuals with diabetes,
14 individuals with obesity, and 4 individuals
with concurrent diabetes, obesity, and hyper-
tension, suggesting that individuals with con-
ditions often associated with both chronic
inflammation and increased cardiac risk
(Libby 2002) may be more vulnerable to the
short-term proinﬂammatory effects of air pol-
lution. This hypothesis is supported by the
finding that individuals with the highest
mean or median levels of inﬂammatory mark-
ers also had larger associations between air
pollution and CRP, IL-6, and WBC counts.
For all three outcomes investigated,
associations were strongest with PM2.5.
Consistent associations were also generally
seen for ambient BC and NO2, indicating
that motor vehicles may be an important
source for PM-mediated inflammation.
Although inconsistent associations were
observed between ambient CO (another
marker of traffic pollution) and inflamma-
tion, this may be due to measurement error
because 95% of the hourly CO concentra-
tions were lower than the 1 ppm sensitivity of
the reference method (Cogan and Lobert
1998). O3 and/or regional pollution may also
be partly responsible for the observed relation-
ships because positive associations were found
between ambient O3 and CRP and IL-6.
Because these relationships were generally not
Air pollution and markers of inflammation
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Figure 1. Overall associations between ambient PM2.5 and markers of inflammation. All models were
adjusted for sex, diabetes, obesity, smoking history, ambient and microenvironmental apparent tempera-
ture, trip, pollen, mold, hour, and vitamin use. IQRs for PM2.5 were 10, 7.7, 7.2, 5.2, 6.1, 5.3, and 5.4 µg/m3 for
the 1, 2-, 3-, 4-, 5-, 6-, and 7-day moving averages, respectively. Error bars indicate 95% CIs.
Figure 2. Effect modiﬁcation of associations between ambient PM2.5 and CRP by risk factor (n = number of
individuals). All models were adjusted for sex, diabetes, obesity, smoking history, ambient and micro-
environmental apparent temperature, trip, pollen, mold, hour, and vitamin use. Error bars indicate 95% CIs.
*Statistically signiﬁcant interaction at the 95% conﬁdence level.
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Moving averages of exposure over the previous 1–7 dayssensitive to stratiﬁcation by season, confound-
ing by PM2.5 is not likely. Associations
between O3 and WBC counts, on the other
hand, did change sign by season, correspond-
ing to the seasonal change in the correlation
between O3 and PM2.5. This suggests that
there may be confounding between PM2.5
and O3 with respect to WBCs.
Because our reported associations were pre-
dominantly for ambient concentrations of air
pollution, there may be some level of measure-
ment error that is inherent to this investiga-
tion. We do not believe that this error is likely
to be substantial, however, because moderately
strong correlations were observed between
daily concentrations of PM2.5 measured at
ambient and microenvironmental monitors,
and these correlations should increase with
longer averaging periods. Strong correlations
across space also have been previously reported
in this region for PM2.5 from both sulfate and
motor vehicles (Kim et al. 2005). In addition,
our results are supported by the finding of
similar associations with ambient concentra-
tions and concentrations of PM2.5 measured in
participants’ microenvironments over the time
periods when both data were available.
Although our ﬁndings suggest that trafﬁc
may be an important source type for the
inflammatory effects of air pollution, it is
unlikely that our bus trips are responsible for
the observed associations because the critical
averaging periods were on the order of days
rather than hours. Because bus periods lasted
only 2 hr, the contribution of the bus to
exposures averaged over several days was small
compared with that of ambient pollution. In
fact, when our analysis was limited to expo-
sures that occurred only on the bus, the effect
estimates were similar in direction to our
main analysis but were smaller in magnitude,
likely due to greater measurement error.
Nevertheless, we cannot exclude the possibility
that a speciﬁc inﬂammatory effect of the bus
might have occurred in addition to the overall
cumulative effects of ambient pollution. Such
an effect might have been seen if we had mea-
sured markers of inflammation immediately
before and after each trip, but we were unable
to collect samples for reasons of feasibility and
acceptability to our participants. We do not
believe this to be a critical flaw, however,
because we have less reason to suspect that
pollution would have near-immediate associa-
tions with our inflammatory markers, given
that other investigations of outcomes related
to inflammation demonstrated associations
on the order of days to a week (O’Neill et al.
2005; Peters et al. 2001b; Seaton et al. 1999;
Zanobetti et al. 2004).
In addition to the timing of our associa-
tions, our results are generally consistent with
other investigations with respect to direction-
ality and magnitude of the associations for
each of our inﬂammatory markers. For exam-
ple, several past investigations have illustrated
positive associations between ambient PM
and CRP in the blood of older adults (Peters
et al. 2001b; Pope et al. 2004; Seaton et al.
1999). Seaton et al. (1999) reported a 9.5%
increase in CRP per 10 µg/m3 in the 3-day
mean ambient PM10. This was comparable
with our findings of an 11% increase per
10 µg/m3 in the 5-day mean PM2.5 for indi-
viduals without concurrent diabetes, obesity,
and hypertension. Similarly, the timing of the
association between PM and CRP for our
study was consistent with past work as the
Monitoring of Trends and Determinants in
Cardiovascular Disease (MONICA) study also
reported its maximum effect with the 5-day
mean (Peters et al. 2001b). Interestingly, our
ﬁndings among seniors with low susceptibility
also were similar to associations reported for a
cohort of young policemen who exhibited a
21–32% change in CRP per 10 µg/m3 increase
in mean PM2.5 over their 9-hr shift (Riediker
et al. 2004).
Only one study of 30 young Singaporean
national guardsmen has reported statistically
signiﬁcant associations between air pollution
and IL-6 in blood (van Eeden et al. 2001).
Other investigations have generally reported
null associations between air pollution and
IL-6, in agreement with our study population
as a whole (Ghio et al. 2000; Nightingale et al.
2000). Despite this general lack of findings,
elevated IL-6 has been found in human spu-
tum (Nordenhall et al. 2000) and alveolar
macrophages (Becker et al. 1996; van Eeden
et al. 2001) after exposures to PM. In fact,
PM from St. Louis was found to induce IL-6
from human alveolar macrophages with
greater potency than diesel, silicon dioxide,
and latex particles (Becker et al. 1996). Our
ﬁndings also are supported by the fact that our
associations with CRP are generally consistent
with, and may lag those of, its precursor (IL-6)
Dubowsky et al.
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Figure 4. Effect modiﬁcation of associations between ambient PM2.5 and markers of inﬂammation by mean
inﬂammatory level (n = number of individuals). All models were adjusted for sex, diabetes, obesity, smoking
history, ambient and microenvironmental apparent temperature, trip, pollen, mold, hour, and vitamin use.
Error bars indicate 95% CIs.
*Statistically signiﬁcant interaction at the 95% conﬁdence level. 
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Figure 3. Effect modiﬁcation of associations between ambient PM2.5 and IL-6 by risk factor (n = number of
individuals). All models were adjusted for sex, diabetes, obesity, smoking history, ambient and micro-
environmental apparent temperature, trip, pollen, mold, hour, and vitamin use. Error bars indicate 95% CIs.
*Statistically signiﬁcant interaction at the 95% conﬁdence level.among individuals with diabetes, obesity, and
hypertension.
Inconclusive evidence links short-term
changes in WBC counts to air pollution expo-
sures. Two investigations that found signifi-
cant results for WBC counts had opposite
findings (Ghio et al. 2003; Schwartz 2001),
and other investigations have reported null
associations (Holgate et al. 2003; Pope et al.
2004; Seaton et al. 1999). Because all of these
investigations examined associations with pol-
lution for durations < 3 days, it is possible that
associations would become more consistent
with longer averaging periods. Alternatively, as
a composite of various cell types, WBC counts
may not perform well as an indicator of the
inﬂammatory effects of air pollution. Finally,
it is possible that the response of WBCs to
PM may be best measured locally in the lung
rather than systemically.
Although our main results are consistent
with other investigations, this study is novel in
that it suggests that individuals with conditions
associated with chronic inflammation may
have an increased short-term inflammatory
response to air pollution. One important limi-
tation of this investigation, however, is the
small number of individuals studied. In our
most susceptible group, only 4 individuals with
14 measurements were classiﬁed as having con-
current diabetes, obesity, and hypertension.
Despite these low numbers, our ﬁndings with-
stood several sensitivity checks. For example,
our diabetes and obesity findings for 8 and
14 individuals, respectively, were robust to the
exclusion of individuals with concurrent condi-
tions. Similarly, no one individual dominated
our results for persons with concurrent dia-
betes, obesity, and hypertension, and individu-
als without any of these three conditions
demonstrated lower associations with air pollu-
tion. Our overall ﬁndings also were robust to
various modeling strategies, including the use
of different confounders and the use of ﬁxed
effects for each subject. In addition, conﬁrma-
tory analyses supported the suggestion of sus-
ceptibility by inflammatory status, because
individuals with higher levels of mean inﬂam-
matory markers demonstrated elevated associa-
tions with pollution. Similarly, we found a
suggestion of reduced associations between air
pollution and CRP with use of anti-inﬂamma-
tory statins. Despite these assurances, future
research is still needed to conﬁrm our ﬁndings
of effect modiﬁcation.
To our knowledge, few investigations have
attempted to investigate effect modiﬁcation of
short-term associations between air pollution
and inflammation by chronic inflammation
directly. One study, conducted in England,
evaluated the inﬂuence of air pollution on the
odds of myocardial infarction or stroke based
on baseline levels of ﬁbrinogen. Their ﬁndings
implied that individuals with elevated inﬂam-
mation were marginally more susceptible than
normal individuals on high-pollution days
(Prescott et al. 2000). Another study demon-
strated that asthmatic children who were not on
anti-inflammatory medications exhibited
stronger associations between respiratory
symptoms and PM10 than did those on anti-
inﬂammatory medications (Delﬁno et al. 2002).
Although our investigation is suggestive
that chronic inflammation leads to an
enhanced vulnerability to the short-term
inflammatory effects of ambient PM, other
interconnected aspects of diabetes, obesity,
and hypertension may also contribute to the
susceptibility of individuals with these disease
states. Possible alternative mechanisms include
enhanced insulin resistance, hyperglycemia,
oxidative stress, and endothelial dysfunction
(Brunner et al. 2005; Libby 2002; O’Neill
et al. 2005). These factors may play a role in
this study given that some but not all of our
diabetic, obese, and hypertensive participants
had measurable manifestations of a chronic
inﬂammatory state.
Overall, the ﬁndings of this investigation
may have important implications for the bio-
logic mechanism of air pollution and possibly
its clinical relevance, because inflammation
plays an important role in atherosclerosis and
cardiovascular disease (Libby 2002). Chronic
levels of both CRP and IL-6 have been identi-
fied as important risk factors for adverse
cardiovascular outcomes (Danesh et al. 2004;
Luc et al. 2003; Ridker et al. 2000). Although
short-term changes in inflammation are less
well understood and may differ from chronic
changes, our findings still offer a potential
explanation as to why individuals with dia-
betes, coronary artery disease, and past myo-
cardial infarctions have elevated cardiovascular
risk after acute exposures to air pollution
(Bateson and Schwartz 2004; Goldberg et al.
2001; Libby 2002; O’Neill et al. 2005;
Zanobetti and Schwartz 2002). It also raises
the possibility that there is an interaction
between the short- and long-term effects of air
pollution, given that previous investigations
have linked elevated exposures to PM to the
development of chronic inﬂammatory condi-
tions such as asthma and atherosclerosis
(Delﬁno 2002; Suwa et al. 2002).
In summary, our data suggest that
increases in air pollution may be associated
with increases in systemic inflammation in
older adults. Associations between pollution
and short-term increases in inflammatory
markers were the strongest for individuals
with diabetes; obesity; and concurrent dia-
betes, obesity, and hypertension. Elevated
associations were also found among persons
with higher mean levels of inflammatory
markers. Such ﬁndings support the hypothe-
sis that the cardiovascular effects of air pollu-
tion are partially mediated via inflammation
and suggest that individuals with existing
inﬂammation and existing cardiac risk factors
may be especially susceptible to the inﬂamma-
tory effects of air pollution.
Air pollution and markers of inflammation
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Table 3. Associations (95% CIs) between 5-day mean ambient pollutant concentrations and markers of
inﬂammation by conditions linked to inﬂammation.
CRP IL-6 WBC (× 109/L)
PM2.5
All 14 (–5.4 to 37) –2.1 (–13 to 11) 3.4 (–1.8 to 8.9)
3 Conditions present 81 (21 to 172)*,** 23 (–5.3 to 59) 0.4 (–8.8 to 11)
≤ 2 Conditions present 11 (–7.3 to 33)** –3.1 (–14 to 9.7) 3.6 (–1.7 to 9.1)
BC
All 13 (–0.34 to 28) –0.8 (–8.9 to 8.0) 1.3 (–2.1 to 4.8)
3 Conditions present 49 (16 to 90)*,** 15 (–2.2 to 35)** 0.05 (–5.9 to 6.3)
≤ 2 Conditions present 9.0 (–3.8 to 24)** –2.7 (–11 to 6.2)** 1.5 (–2.0 to 5.1)
CO
All 0.22 (–11 to 13) –5.2 (–12 to 2.7) 2.9 (–0.22 to 6.2)
3 Conditions present –16 (–32 to 4.3) 4.1 (–9.6 to 20) 4.2 (–1.2 to 10)
≤ 2 Conditions present 4.3 (–8.1 to 18) –7.2 (–14 to 1.0) 2.6 (–0.7 to 6.0)
NO2
All 15 (–11 to 49) –2.7 (–18 to 16) 0.3 (–6.3 to 7.4)
3 Conditions present 36 (–5.2 to 94) 8.2 (–12 to 33)** 0.8 (–7.3 to 9.6)
≤ 2 Conditions present 12 (–14 to 45) –6.0 (–21 to 12)** 0.3 (–6.4 to 7.4)
SO2
All –8.3 (–15 to –0.65)* –3.8 (–8.9 to 1.5) 2.3 (0.1 to 4.5)*
3 Conditions present –20 (–50 to 26) 12 (–17 to 50) –0.7 (–11 to 11)
≤ 2 Conditions present –8.0 (–15 to –0.24)* –4.1 (–9.3 to 1.3) 2.3 (0.1 to 4.6)*
O3
All –3.9 (–17 to 11) 8.0 (–1.6 to 19) –2.1 (–5.8 to 1.7)
3 Conditions present 41 (7.6 to 84)*,** 22 (1.9 to 45)* –4.2 (–10 to 2.5)
≤ 2 Conditions present –5.7 (–18 to 8.1)** 7.3 (–2.4 to 18) –2.0 (–5.7 to 1.8)
All models were adjusted for sex, obesity, diabetes, smoking history, ambient and microenvironmental apparent tempera-
ture, mold, pollen, trip, hour, and vitamins. To maximize comparability, only records with complete PM2.5, BC, CO, SO2, and
O3 data were evaluated. The NO2 data were too sparse to fairly limit the data set. IQRs were 6.1 µg/m3, 230 ng/m3,
0.13 ppm, 3.6 ppb, 2.3 ppb, and 7.2 ppb for PM2.5, BC, CO, NO2, SO2, and O3, respectively.
*The association met statistical signiﬁcance at the 95% conﬁdence level. **The interaction met statistical signiﬁcance at
the 95% conﬁdence level.Dubowsky et al.
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CORRECTION
In Table 1 of the manuscript published
online, the ranges of CRP for both “Yes” and
“No” under “Statin therapy” were incorrect.
These values have been corrected here.